FdaApplication
BLA 125764
Identifiers
- fda_app_no: BLA125764
Properties
| Property | Value |
|---|---|
| applicant_name | StemCyte, Inc. |
| application_type | BLA |
| approval_date | 2024-11-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REGENECYTE | — | >/=1.25x10E6 VIABLE CD34+ CELLS/UNIT IN >/=9x10E8 TNCs/UNIT | Injection |
1 product